NICE recommends Revlimid as multiple myeloma alternative
The new indication will benefit approximately 2,100 patients. [...]
Fri, May 17, 2019
Rise in bowel cancer numbers among young adults
Fri, May 17, 2019
Rise in bowel cancer numbers among young adults
The researchers retrieved data on 143.7 million people aged 20 to 49 years from 20 European countries. [...]
Fri, May 17, 2019
Revlimid, Imnovid combos receive EU approval
The approval of these combination therapies “Marks a significant milestone for patients with multiple myeloma in Europe". [...]
Fri, May 17, 2019

 

The Learning  Partnership